IBC Life Sciences Announces Keynote Speakers for the 2011 BioProcess International Conference & Exhibition
WESTBOROUGH, MA--(Marketwire - June 08, 2011) - IBC Life Sciences has confirmed eight keynote speakers for this year's BioProcess International Conference & Exhibition in Long Beach, California from October 31-November 4. Areas being covered include Enhancing Manufacturing and Development Efficiency, Product Lifecycle Management, Cell Culture and Recovery & Purification.
This year's keynote presentations touch upon topics from biosimilars to the industry's future direction:
Overview of Approval Pathway under Biologics Price Competition and Innovation Act of 2009
Steven Kozlowski, M.D. Director, Office of Biotechnology Products, OPS, CDER, US FDA
EMA Draft Guideline on Biosimilar Monoclonal Antibodies
Esa Heinonen, M.D., Ph.D. Member of the EMA Working Group on Biosimilars, Head of Section 2, Marketing Authorizations, Finnish Medicines Agency (Fimea), Finland
Ready or not Biosimilars are Coming to US
Jay S. Stout, Ph.D. Executive Director, Biologics Manufacturing Sciences and Commercialization, Merck & Co., Inc.
Integrating Two Biologics Manufacturing Networks
Tim Moore Senior Vice President, Global Head, Pharmaceutical Technical Operations Biologics, Roche
Bioprocess Technology & Innovation: Strategic Imperative for Challenging Times
Timothy S. Charlebois, Ph.D., Vice President, Technology and Innovation, Strategy, Pfizer
The International Chinese Hamster Ovary Genome Project: Where Do We Go from Here?
Michael Betenbaugh, Ph.D., Professor, Chemical and Biomolecular Engineering, Johns Hopkins University
The Impact of Antibody Drug Conjugates on Process Development and Manufacturing
Morris Rosenberg, Ph.D., Executive Vice President, Process Sciences, Seattle Genetics
Fitting the Glass Slipper: Process Design, Plant Capacity, and Value Realization
Jeffrey C. Baker, Ph.D., Consulting LSS Black Belt, formerly with Eli Lilly and Company and MedImmune
"This year's keynote presenters are the industry's leading experts on the most pressing issues in the field, and we are confident that the complete panel of speakers will provide attendees with very relevant, timely new data to help them streamline their processes," notes conference producer Ellen King.
Additional content includes coverage of Vaccine Development and Production, Analytical Technology Advances, and Viral Clearance along with co- located conference, Formulation Strategies for Protein Therapeutics and four bioprocessing themed training courses.
The exhibit hall will be open November 1-3, 2011 and will showcase the latest array of technologies and services from over 150 exhibitors.
Complete event details can be found at http://www.IBCLifeSciences.com/BPI.